Unveiling the oncogenic role of PDK3 in head and neck squamous cell carcinoma, an integrative in silico and an in vitro approach

Head and neck squamous cell carcinoma (HNSCC) is a clinically aggressive malignancy with a poor prognosis. Emerging evidence highlights the importance of metabolic reprogramming in tumor progression and therapy resistance. However, the mechanisms driving metabolic adaptation in HNSCC remain incompletely understood. Here, we investigate pyruvate dehydrogenase kinase 3 (PDK3), a regulatory enzyme critical for aerobic glycolysis (the Warburg effect) in cancer cells. Using computational analysis and experimental validation, we explored PDK3’s role as an oncogene in HNSCC.

Our gene expression analysis revealed that PDK3 is significantly upregulated in tumors compared to normal tissues. Pathway enrichment analysis linked PDK3 to key metabolic pathways essential for cellular energy production and biosynthesis, including the TCA cycle, pyruvate metabolism, and glycolysis/gluconeogenesis. Additionally, PDK3 upregulation influenced immune cell distribution and drug response. Clinically, elevated PDK3 expression correlated with reduced overall survival in patients.

Functional validation in an HNSCC cell line (HSC3) demonstrated that PDK3 knockdown suppressed growth, proliferation, and migration, suggesting PDK3’s role as a potential tumor promoter in HNSCC. These findings indicate that targeting PDK3 could be a promising therapeutic strategy for HNSCC management.

Loại tài liệu:

Article - Bài báo

Tác giả:

Aishath Shaheeda

Đề mục:

Journal of Genetic Engineering and Biotechnology

Nhà xuất bản:

Elsevier

Ngày xuất bản:

September 2026

Số trang/ tờ:

Định dạng:

pdf

Định danh tư liệu:

DOI: https://doi.org/10.1016/j.jgeb.2026.100768 | ISSN 1687-157X

Nguồn gốc:

Journal of Genetic Engineering and Biotechnology, Volume 24, Issue 3, September 2026, 100768

Loại file Tập tin đính kèm Dung lượng Chi tiết
2026N3JGEB100768.pdf 6692787 Kb Xem Tải